Switch to:
Also traded in: Canada, Germany
» Details

Insider Trades

Latest Guru Trades with BUR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325412    SIC: 3741
Compare:NAS:BCLI, NAS:PULM, OTCPK:CWBR, NAS:CAPR, OTCPK:TBQBF, OTCPK:IMMG, NAS:AGLE, NAS:ALDX, NAS:ADMA, NAS:BLRX, NAS:TCON, AMEX:PIP, AMEX:NAVB, OTCPK:AMEUF, AMEX:NBY, OTCPK:COTQF, NAS:IPCI, OTCPK:THCBF, OTCPK:AAVXF, NAS:RGLS » details
Traded in other countries:BU.Canada, BNE.Germany,
Burcon NutraScience Corp and its subsidiary are research and development companies that are developing plant protein extraction and purification technology in the field of functional, renewable plant proteins.

Burcon NutraScience Corp was incorporated on November 3, 1998. The Company, through its subsidiary, Burcon NutraScience (MB) Corp. is a research and development company building a portfolio of composition, application and process patents around its plant protein extraction and purification technology. The Company's products include CLARISOY, a soy protein isolate, which is used in various food products, including protein shakes, power bars, soups and sauces, meats and meat analogs, and breads and baked foods; and PEAZAZZ, a soluble pea protein isolate. Its products also comprise canola protein isolates, such as Supertein that comprises albumin proteins used in beverages, confectionery, aerated desserts, and protein bars; Puratein, which consists of globulin proteins used in dressings and sauces, meat substitutes, baked goods, and protein bars.

Ratios

vs
industry
vs
history
P/B 15.99
BUR's P/B is ranked lower than
92% of the 1106 Companies
in the Global Biotechnology industry.

( Industry Median: 3.65 vs. BUR: 15.99 )
Ranked among companies with meaningful P/B only.
BUR' s P/B Range Over the Past 10 Years
Min: 7.95  Med: 16.35 Max: 86.58
Current: 15.99
7.95
86.58
P/S 587.50
BUR's P/S is ranked lower than
93% of the 853 Companies
in the Global Biotechnology industry.

( Industry Median: 12.50 vs. BUR: 587.50 )
Ranked among companies with meaningful P/S only.
BUR' s P/S Range Over the Past 10 Years
Min: 460  Med: 747.5 Max: 3540
Current: 587.5
460
3540
Current Ratio 2.47
BUR's Current Ratio is ranked lower than
69% of the 950 Companies
in the Global Biotechnology industry.

( Industry Median: 4.13 vs. BUR: 2.47 )
Ranked among companies with meaningful Current Ratio only.
BUR' s Current Ratio Range Over the Past 10 Years
Min: 0.82  Med: 9.45 Max: 55.01
Current: 2.47
0.82
55.01
Quick Ratio 2.47
BUR's Quick Ratio is ranked lower than
65% of the 948 Companies
in the Global Biotechnology industry.

( Industry Median: 3.91 vs. BUR: 2.47 )
Ranked among companies with meaningful Quick Ratio only.
BUR' s Quick Ratio Range Over the Past 10 Years
Min: 0.82  Med: 9.45 Max: 55.01
Current: 2.47
0.82
55.01
Days Sales Outstanding 162.95
BUR's Days Sales Outstanding is ranked lower than
86% of the 592 Companies
in the Global Biotechnology industry.

( Industry Median: 62.87 vs. BUR: 162.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
BUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 425.83  Med: 515.46 Max: 541.74
Current: 162.95
425.83
541.74

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 0.60
BUR's Yield on cost (5-Year) is ranked lower than
80% of the 281 Companies
in the Global Biotechnology industry.

( Industry Median: 1.71 vs. BUR: 0.60 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
BUR' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.6
3-Year Average Share Buyback Ratio -3.90
BUR's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 556 Companies
in the Global Biotechnology industry.

( Industry Median: -10.90 vs. BUR: -3.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
BUR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -42.4  Med: -5.7 Max: -2
Current: -3.9
-42.4
-2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 26.11
BUR's Price/Net Cash is ranked lower than
86% of the 749 Companies
in the Global Biotechnology industry.

( Industry Median: 5.89 vs. BUR: 26.11 )
Ranked among companies with meaningful Price/Net Cash only.
BUR' s Price/Net Cash Range Over the Past 10 Years
Min: 2.61  Med: 22.5 Max: 225
Current: 26.11
2.61
225
Price/Net Current Asset Value 23.50
BUR's Price/Net Current Asset Value is ranked lower than
88% of the 879 Companies
in the Global Biotechnology industry.

( Industry Median: 5.57 vs. BUR: 23.50 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
BUR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.56  Med: 21.31 Max: 134
Current: 23.5
2.56
134
Price/Tangible Book 20.80
BUR's Price/Tangible Book is ranked lower than
92% of the 1015 Companies
in the Global Biotechnology industry.

( Industry Median: 4.36 vs. BUR: 20.80 )
Ranked among companies with meaningful Price/Tangible Book only.
BUR' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.43  Med: 14.91 Max: 1076.67
Current: 20.8
2.43
1076.67
Price/Median PS Value 0.79
BUR's Price/Median PS Value is ranked higher than
66% of the 765 Companies
in the Global Biotechnology industry.

( Industry Median: 0.97 vs. BUR: 0.79 )
Ranked among companies with meaningful Price/Median PS Value only.
BUR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.68  Med: 1.06 Max: 4
Current: 0.79
0.68
4
Earnings Yield (Greenblatt) (%) -6.80
BUR's Earnings Yield (Greenblatt) (%) is ranked higher than
56% of the 1203 Companies
in the Global Biotechnology industry.

( Industry Median: -9.03 vs. BUR: -6.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
BUR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -11.1  Med: 0 Max: 0
Current: -6.8
-11.1
0

More Statistics

Revenue (TTM) (Mil) $0.09
EPS (TTM) $ -0.12
Beta1.03
Short Percentage of Float0.18%
52-Week Range $1.51 - 2.87
Shares Outstanding (Mil)37.83

Analyst Estimate

Mar17 Mar18
Revenue (Mil $) 2 9
EPS ($) -0.08 0.06
EPS w/o NRI ($) -0.08 0.06
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:BUR

Headlines

Articles On GuruFocus.com
Burelle: A Growing Euro for 50 cents Mar 12 2013 

More From Other Websites
Burcon reports 3Q loss Feb 10 2017
Burcon reports 3Q loss Feb 10 2017
Burcon Announces Details of Over-Subscribed Rights Offering Dec 09 2016
BURCON ANNOUNCES COMPLETION OF OVER-SUBSCRIBED RIGHTS OFFERING Dec 01 2016
Burcon Announces Completion of Over-Subscribed Rights Offering Dec 01 2016
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: Q2, 2017 By the Numbers : November 29, 2016 Nov 29 2016
FIRST LARGE-SCALE CLARISOY™ PRODUCTION FACILITY FULLY COMMISSIONED Nov 08 2016
ETF’s with exposure to Burcon NutraScience Corp. : October 17, 2016 Oct 17 2016
ETF’s with exposure to Burcon NutraScience Corp. : October 5, 2016 Oct 05 2016
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: Q1, 2017 By the Numbers : October 4, 2016 Oct 04 2016
FIRST LARGE-SCALE CLARISOY™ PRODUCTION FACILITY SCHEDULED TO BE COMMISSIONED IN FOURTH QUARTER Sep 06 2016
The Zacks Analyst Blog Highlights: Hershey's, Coach, Sysco, Burcon Nutrascience and Barfresh Food... Aug 12 2016
Consumer Stock Earnings Around the Corner: SYY, BUR, BRFH Aug 11 2016
Burford Capital Ltd. :BUR-GB: Earnings Analysis: For the six months ended June 30, 2016 : August 8,... Aug 08 2016
BURCON NUTRASCIENCE CORP Financials Aug 02 2016
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 Jul 26 2016
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: Q4, 2016 By the Numbers : July 8, 2016 Jul 08 2016
BURCON ANNOUNCES FISCAL 2016 RESULTS AND REVIEWS OPERATIONS Jun 27 2016
BURCON ANNOUNCES CONVERTIBLE NOTE FINANCING Apr 07 2016
Burcon NutraScience Corp. :BUR-US: Earnings Analysis: Q3, 2016 By the Numbers Apr 07 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK